Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Current Assets (2016 - 2025)

Historic Current Assets for Healthequity (HQY) over the last 12 years, with Q4 2025 value amounting to $498.7 million.

  • Healthequity's Current Assets rose 69.9% to $498.7 million in Q4 2025 from the same period last year, while for Oct 2025 it was $498.7 million, marking a year-over-year increase of 69.9%. This contributed to the annual value of $477.7 million for FY2025, which is 1429.53% down from last year.
  • According to the latest figures from Q4 2025, Healthequity's Current Assets is $498.7 million, which was up 69.9% from $492.8 million recorded in Q3 2025.
  • In the past 5 years, Healthequity's Current Assets registered a high of $865.1 million during Q2 2021, and its lowest value of $278.9 million during Q2 2022.
  • Moreover, its 5-year median value for Current Assets was $473.6 million (2023), whereas its average is $487.7 million.
  • Its Current Assets has fluctuated over the past 5 years, first soared by 20484.95% in 2021, then crashed by 6775.87% in 2022.
  • Over the past 5 years, Healthequity's Current Assets (Quarter) stood at $764.1 million in 2021, then tumbled by 56.53% to $332.2 million in 2022, then skyrocketed by 42.83% to $474.4 million in 2023, then rose by 4.39% to $495.2 million in 2024, then grew by 0.7% to $498.7 million in 2025.
  • Its Current Assets was $498.7 million in Q4 2025, compared to $492.8 million in Q3 2025 and $472.8 million in Q2 2025.